Nerivio Migra®

Israel-based Theranica raises $35M in series B funding
By Dean Koh | 01:02 am | March 19, 2019
Founded in 2016, Theranica, a biomedical technology company focused on developing advanced electroceuticals for migraine and other prevalent diseases, yesterday announced the closing of its round B of financing, of $35M, led by aMoon, Israel's largest healthcare VC.